Fiera Capital (Canada)
JAZZ icon

Fiera Capital (Canada)’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fiera Capital (Canada)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-298,187
Closed -$37M – 680
2018
Q4 		$37M Sell
298,187
-17,994
-6% -$2.67M 0.17% 111
2018
Q3 		$53.2M Sell
316,181
-1,067
-0.3% -$183K 0.21% 92
2018
Q2 		$54.7M Buy
+317,248
New +$51.9M 0.24% 88
2017
Q1 		– Sell
-44,800
Closed -$4.88M – 709
2016
Q4 		$4.88M Sell
44,800
-277,853
-86% -$30.9M 0.03% 323
2016
Q3 		$39.2M Sell
322,653
-9,627
-3% -$1.3M 0.22% 108
2016
Q2 		$47M Buy
+332,280
New +$49M 0.26% 96
2016
Q1 		– Sell
-2,260
Closed -$318K – 593
2015
Q4 		$318K Sell
2,260
-2,535
-53% -$351K ﹤0.01% 517
2015
Q3 		$637K Sell
4,795
-1,500
-24% -$258K 0.01% 411
2015
Q2 		$1.11K Buy
+6,295
New +$1.13M 0.01% 393
2015
Q1 		– Sell
-32,300
Closed -$5.29M – 451
2014
Q4 		$5.29M Sell
32,300
-11,300
-26% -$1.88M 0.04% 196
2014
Q3 		$7M Buy
43,600
+2,900
+7% +$446K 0.05% 176
2014
Q2 		$5.98M Buy
40,700
+5,600
+16% +$777K 0.03% 210
2014
Q1 		$4.87M Buy
35,100
+2,600
+8% +$391K 0.04% 210
2013
Q4 		$4.11M Buy
+32,500
New +$3.36M 0.03% 221

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fiera Capital (Canada)'s JAZZ Position: Q1 2019 in Review

Fiera Capital (Canada) sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2019, closing a stake of 298,187 shares — an estimated $37M sold.

Fiera Capital (Canada) first reported a position in JAZZ in Q4 2013 and held it in 14 quarters. The position peaked at $54.7M in Q2 2018. 427 funds tracked by Wall St. Rank hold JAZZ as of Q1 2019.

  • Fiera Capital (Canada) reported no remaining Jazz Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Fiera Capital (Canada) sold 298,187 Jazz Pharmaceuticals shares in Q1 2019, an estimated $37M.
  • Fiera Capital (Canada) first reported a position in Jazz Pharmaceuticals in Q4 2013 and held it in 14 quarters.
  • Fiera Capital (Canada)'s Jazz Pharmaceuticals position peaked at $54.7M in Q2 2018.
  • 427 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2019.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2019, filed 10 May 2019.